Genetic Risk for Psychiatric Disorders and Telomere Length.
Ontology highlight
ABSTRACT: Background: Previous studies have revealed associations between psychiatric disorder diagnosis and shorter telomere length. Here, we attempt to discern whether genetic risk for psychiatric disorders, or use of pharmacological treatments (i.e., antidepressants), predict shorter telomere length and risk for aging-related disease in a United Kingdom population sample. Methods: DNA samples from blood were available from 351 participants who were recruited as part of the South East London Community Health (SELCoH) Study, and for which whole-genome genotype data was available. Leukocyte telomere length was characterized using quantitative polymerase chain reactions. Individualized polygenic risk scores for major depressive disorder (MDD), bipolar disorder (BD), and schizophrenia (S
SUBMITTER: Palmos AB
PROVIDER: S-EPMC6232668 | biostudies-literature | 2018
REPOSITORIES: biostudies-literature
ACCESS DATA